Govt Approved ₹480 Crore To Develop Talent Pool For Medical Devices Sector

NEW DELHI : The government has approved a rs 480 crore scheme to develop a talent pool that will drive the medical devices industry.

The three-year scheme will provide financial assistance to government institutions for running multiple courses on medical devices, upgrading such institutions to global standards.

The move follows the recent announcement of the National Medical Device Policy, 2023, that will help the medical devices sector grow from the present $11 billion to $50 billion by 2030.

“There is a need to have a steady supply of skilled workforce across the medical device sector. For skilling, reskilling and upskilling of professionals in the medical sector, the department may leverage the available resources in ministry of skill development and entrepreneurship,” said an official from the department of pharmaceuticals.

Beside this, the new scheme will support dedicated multidisciplinary courses for medical devices in existing institutions to ensure availability of skilled manpower for futuristic medical technologies, high-end manufacturing and research.

These in turn will produce future-ready medtech human resources and meet the evolving needs of the sector.

“The plan is also to leverage partnerships with foreign academia or industry organizations to develop medical technologies so that India can compete with the world market,” said the official.

India is 80% dependent on imported medical devices.

Industry experts say that the covid-19 pandemic brought the government focus on medical devices when international supply chains became disrupted.

This prompted India to take urgent steps to manufacture masks, PPE kits, gloves, sanitizers, thermometers, oximeters and oxygen therapy equipment like invasive and non-invasive ventilators, which were imported.

“India is 75-80% import dependent with last two years imports being over ₹60,000 crore and this year the government announced the Medical Devices Policy in which a key strategy indicator was Human Resources Development. We are glad that the policy is being backed by financial outlay to enable government institutions to make tailor-made courses to develop expertise in diverse technologies deployed in medical devices–electronics, metallurgy, electrical, polymer, rubber, chemical and biomedical engineering along with nanotechnology with regulatory and quality management systems,” said Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AIMED).

Related Posts

  • Pharma
  • April 25, 2025
  • 21 views
Laurus Labs Q4 net surges to Rs 234 cr. on higher CDMO revenue

Drugmaker Laurus Labs reported consolidated net profit for the March quarter surged to ₹233.87 crore from ₹75.32 crore a year earlier on a 19% increase in the revenue. Revenue from…

  • Pharma
  • April 25, 2025
  • 85 views
Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively

New Delhi:  In a relief to pharma companies, including Glenmark Pharmaceuticals and Zuventus Healthcare, the Delhi High Court on Thursday held that the government’s April 15 notification that prohibited the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Laurus Labs Q4 net surges to Rs 234 cr. on higher CDMO revenue

Laurus Labs Q4 net surges to Rs 234 cr. on higher CDMO revenue

Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively

Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively

Novo Nordisk to phase out country’s largest insulin brand

Novo Nordisk to phase out country’s largest insulin brand

18 drugs found substandard in Telangana

18 drugs found substandard in Telangana